Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
35 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Etubics Corporation - Product Pipeline Review - 2016 Summary
Global Markets Direct's, 'Etubics Corporation - Product Pipeline Review - 2016', provides an overview of the Etubics Corporation's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Etubics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Etubics Corporation - The report provides overview of Etubics Corporation including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Etubics Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Etubics Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Etubics Corporation's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Etubics Corporation - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Etubics Corporation's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Etubics Corporation Snapshot 5 Etubics Corporation Overview 5 Key Information 5 Key Facts 5 Etubics Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 Etubics Corporation - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Etubics Corporation - Pipeline Products Glance 11 Etubics Corporation - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Etubics Corporation - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Etubics Corporation - Drug Profiles 14 ETBX-011 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Ebola vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 ETBX-021 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Gene Therapy for Auditory Disorders 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Gene Therapy to Activate Acid Alpha-Glucosidase for Pompe Disease 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 HIV vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 influenza [strain H1N1] (mutivalent) vaccine 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Vaccine for HPV Associated Head and Neck Squamous Cell Carcinoma 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Vaccine for Oncology 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 chikungunya vaccine 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 lassa fever vaccine 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Etubics Corporation - Pipeline Analysis 26 Etubics Corporation - Pipeline Products by Target 26 Etubics Corporation - Pipeline Products by Route of Administration 27 Etubics Corporation - Pipeline Products by Molecule Type 28 Etubics Corporation - Pipeline Products by Mechanism of Action 29 Etubics Corporation - Recent Pipeline Updates 30 Etubics Corporation - Dormant Projects 32 Etubics Corporation - Locations and Subsidiaries 33 Head Office 33 Appendix 34 Methodology 34 Coverage 34 Secondary Research 34 Primary Research 34 Expert Panel Validation 34 Contact Us 34 Disclaimer 35
List of Tables
Etubics Corporation, Key Information 5 Etubics Corporation, Key Facts 5 Etubics Corporation - Pipeline by Indication, 2016 8 Etubics Corporation - Pipeline by Stage of Development, 2016 9 Etubics Corporation - Monotherapy Products in Pipeline, 2016 10 Etubics Corporation - Phase I, 2016 11 Etubics Corporation - Preclinical, 2016 12 Etubics Corporation - Discovery, 2016 13 Etubics Corporation - Pipeline by Target, 2016 26 Etubics Corporation - Pipeline by Route of Administration, 2016 27 Etubics Corporation - Pipeline by Molecule Type, 2016 28 Etubics Corporation - Pipeline Products by Mechanism of Action, 2016 29 Etubics Corporation - Recent Pipeline Updates, 2016 30 Etubics Corporation - Dormant Developmental Projects,2016 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.